Neuroinflammation in Neurodegenerative Diseases: Current Multi-modal Imaging Studies and Future Opportunities for Hybrid PET/MRI

Marco Aiello, Carlo Cavaliere, Dario Fiorenza, Andrea Duggento, Luca Passamonti, Nicola Toschi

Research output: Contribution to journalArticle

Abstract

Positron emission tomography (PET) provides spatially localized information about brain metabolism and function and innovative tracers have extended this potential to the study of neuroinflammation (NI), an important process in the pathophysiology of several neurological disorders. However, PET is limited by low spatial resolution. Conversely, Magnetic Resonance Imaging (MRI) affords high-resolution information about brain anatomy and metabolism which can complement PET-related information as well as aid in post-processing of PET data. For sequentially acquired MR/PET data, anatomical correspondence is often capped by the limited structural detail afforded by PET, and the assumption that no significant changes in subject state has occurred between sessions. Hybrid PET/MRI offers the unique opportunity to overcome these limitations by providing access to temporal and spatial cross-modal alignment/synchronization, hence opening novel avenues for exploiting multivariate and multiparametric information regarding brain structure and function. While, the clinical applicability and impact on diagnostic accuracy of PET/MRI in neurological disorders is still under investigation, the study of NI, a complex processes mediated by multiple metabolic pathways and hence likely characterized by different biomarkers, represents an opportunity to characterize the added value of joint MRI-PET techniques in a clinical context. This would in turn offer improved diagnostic and prognostic tools in several neurological disorders in which NI is a key mediator. This review aims at summarizing the current state as well as future potential of using hybrid PET/MRI for characterizing NI phenomena, both in terms of technical challenges and clinical relevance.

Original languageEnglish
JournalNeuroscience
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Neurodegenerative Diseases
Positron-Emission Tomography
Magnetic Resonance Imaging
Nervous System Diseases
Brain
Metabolic Networks and Pathways
Anatomy
Joints
Biomarkers

Keywords

  • dual tracers
  • hybrid Imaging
  • MRI
  • multimodal
  • neuroinflammation
  • PET

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

@article{748824b4ab0f4dd78d0356a7ed8dbbe2,
title = "Neuroinflammation in Neurodegenerative Diseases: Current Multi-modal Imaging Studies and Future Opportunities for Hybrid PET/MRI",
abstract = "Positron emission tomography (PET) provides spatially localized information about brain metabolism and function and innovative tracers have extended this potential to the study of neuroinflammation (NI), an important process in the pathophysiology of several neurological disorders. However, PET is limited by low spatial resolution. Conversely, Magnetic Resonance Imaging (MRI) affords high-resolution information about brain anatomy and metabolism which can complement PET-related information as well as aid in post-processing of PET data. For sequentially acquired MR/PET data, anatomical correspondence is often capped by the limited structural detail afforded by PET, and the assumption that no significant changes in subject state has occurred between sessions. Hybrid PET/MRI offers the unique opportunity to overcome these limitations by providing access to temporal and spatial cross-modal alignment/synchronization, hence opening novel avenues for exploiting multivariate and multiparametric information regarding brain structure and function. While, the clinical applicability and impact on diagnostic accuracy of PET/MRI in neurological disorders is still under investigation, the study of NI, a complex processes mediated by multiple metabolic pathways and hence likely characterized by different biomarkers, represents an opportunity to characterize the added value of joint MRI-PET techniques in a clinical context. This would in turn offer improved diagnostic and prognostic tools in several neurological disorders in which NI is a key mediator. This review aims at summarizing the current state as well as future potential of using hybrid PET/MRI for characterizing NI phenomena, both in terms of technical challenges and clinical relevance.",
keywords = "dual tracers, hybrid Imaging, MRI, multimodal, neuroinflammation, PET",
author = "Marco Aiello and Carlo Cavaliere and Dario Fiorenza and Andrea Duggento and Luca Passamonti and Nicola Toschi",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.neuroscience.2018.07.033",
language = "English",
journal = "Neuroscience",
issn = "0306-4522",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Neuroinflammation in Neurodegenerative Diseases

T2 - Current Multi-modal Imaging Studies and Future Opportunities for Hybrid PET/MRI

AU - Aiello, Marco

AU - Cavaliere, Carlo

AU - Fiorenza, Dario

AU - Duggento, Andrea

AU - Passamonti, Luca

AU - Toschi, Nicola

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Positron emission tomography (PET) provides spatially localized information about brain metabolism and function and innovative tracers have extended this potential to the study of neuroinflammation (NI), an important process in the pathophysiology of several neurological disorders. However, PET is limited by low spatial resolution. Conversely, Magnetic Resonance Imaging (MRI) affords high-resolution information about brain anatomy and metabolism which can complement PET-related information as well as aid in post-processing of PET data. For sequentially acquired MR/PET data, anatomical correspondence is often capped by the limited structural detail afforded by PET, and the assumption that no significant changes in subject state has occurred between sessions. Hybrid PET/MRI offers the unique opportunity to overcome these limitations by providing access to temporal and spatial cross-modal alignment/synchronization, hence opening novel avenues for exploiting multivariate and multiparametric information regarding brain structure and function. While, the clinical applicability and impact on diagnostic accuracy of PET/MRI in neurological disorders is still under investigation, the study of NI, a complex processes mediated by multiple metabolic pathways and hence likely characterized by different biomarkers, represents an opportunity to characterize the added value of joint MRI-PET techniques in a clinical context. This would in turn offer improved diagnostic and prognostic tools in several neurological disorders in which NI is a key mediator. This review aims at summarizing the current state as well as future potential of using hybrid PET/MRI for characterizing NI phenomena, both in terms of technical challenges and clinical relevance.

AB - Positron emission tomography (PET) provides spatially localized information about brain metabolism and function and innovative tracers have extended this potential to the study of neuroinflammation (NI), an important process in the pathophysiology of several neurological disorders. However, PET is limited by low spatial resolution. Conversely, Magnetic Resonance Imaging (MRI) affords high-resolution information about brain anatomy and metabolism which can complement PET-related information as well as aid in post-processing of PET data. For sequentially acquired MR/PET data, anatomical correspondence is often capped by the limited structural detail afforded by PET, and the assumption that no significant changes in subject state has occurred between sessions. Hybrid PET/MRI offers the unique opportunity to overcome these limitations by providing access to temporal and spatial cross-modal alignment/synchronization, hence opening novel avenues for exploiting multivariate and multiparametric information regarding brain structure and function. While, the clinical applicability and impact on diagnostic accuracy of PET/MRI in neurological disorders is still under investigation, the study of NI, a complex processes mediated by multiple metabolic pathways and hence likely characterized by different biomarkers, represents an opportunity to characterize the added value of joint MRI-PET techniques in a clinical context. This would in turn offer improved diagnostic and prognostic tools in several neurological disorders in which NI is a key mediator. This review aims at summarizing the current state as well as future potential of using hybrid PET/MRI for characterizing NI phenomena, both in terms of technical challenges and clinical relevance.

KW - dual tracers

KW - hybrid Imaging

KW - MRI

KW - multimodal

KW - neuroinflammation

KW - PET

UR - http://www.scopus.com/inward/record.url?scp=85051121327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85051121327&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2018.07.033

DO - 10.1016/j.neuroscience.2018.07.033

M3 - Article

AN - SCOPUS:85051121327

JO - Neuroscience

JF - Neuroscience

SN - 0306-4522

ER -